What’s Next For Gene Therapy?

Gene therapy is at a pivotal moment. For eligible rare disease patients, the potential impact could be huge. So how can we support that potential to fruition and what will it mean if we do? In our season finale, host Adam Rutherford and guests take a peek into what a world with successful gene therapies could look like for patients, healthcare and society.Featuring guests:Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare DisordersErik Paulsen, Chair, Institute for Gene TherapiesKarolina Hanslik, Former Senior Project Manager, EURORDISNikhil Gadre, Senior Director, Global Commercial, Hemophilia Gene Therapy, PfizerPaige Bischoff, Senior Vice President, Global Public Affairs,  Alliance for Regenerative MedicinePaolo Morgese, EU Director, Market Access, Alliance for Regenerative MedicineReda Guiha, IDM Regional President, Rare Disease, PfizerSimone Boselli, Director, Public Affairs, EURORDISTomislav Sokol, Member of European Parliament